Across TCGA pan-cancer cohorts, RPL26P34 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL26P34’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RPL26P34 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL26P34 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA and LUSC are the cancer types where RPL26P34 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL26P34 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.022	.029	2	view →
LUSC	All	All	+0.030	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPL26P34 RNA expression & survival · all RPL26P34 data types